{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T13:23:36Z","timestamp":1749129816416},"reference-count":23,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Antifungal drugs can affect the cellular morphology of<jats:italic>Cryptococcus neoformans<\/jats:italic>in culture, which alters its interactions with phagocytes. We examined the effects of amphotericin B on<jats:italic>C. neoformans<\/jats:italic>during murine infection. The antifungal reduced capsule size and serum polysaccharide, which suggests an additional mechanism for amphotericin B's efficacy in cryptococcosis.<\/jats:p>","DOI":"10.1128\/aac.49.10.4358-4361.2005","type":"journal-article","created":{"date-parts":[[2005,9,27]],"date-time":"2005-09-27T16:28:08Z","timestamp":1127838488000},"page":"4358-4361","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":14,"title":["Effect of Amphotericin B on Capsule and Cell Size in<i>Cryptococcus neoformans<\/i>during Murine Infection"],"prefix":"10.1128","volume":"49","author":[{"given":"Oscar","family":"Zaragoza","sequence":"first","affiliation":[{"name":"Departments of Microbiology and Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coralia","family":"Mihu","sequence":"additional","affiliation":[{"name":"Medicine, Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Casadevall","sequence":"additional","affiliation":[{"name":"Departments of Microbiology and Immunology"},{"name":"Medicine, Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Nosanchuk","sequence":"additional","affiliation":[{"name":"Medicine, Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.2.183"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(92)90209-C"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)62265-1"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.5.1507-1512.1994"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/152.5.1037"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jac\/27.4.535","volume":"27","year":"1991","unstructured":"Collette, N., P. Van der Auwera, F. Meunier, C. Lambert, J. P. Sculier, and A. Coune. 1991. Tissue distribution and bioactivity of amphotericin B administered in liposomes to cancer patients. J. Antimicrob. Chemother.27:535-548.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_8_2","first-page":"220","volume":"8","year":"1989","unstructured":"Dugoni, B. M., B. J. Guglielmo, and H. Hollander. 1989. Amphotericin B concentrations in cerebral spinal fluid in patients with AIDS and cryptococcal meningitis. Clin. Pharmacol.8:220-221.","journal-title":"Clin. Pharmacol."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-147-8-2355"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.14.5.659"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1172\/JCI110555","volume":"69","year":"1982","unstructured":"Henderson, D. K., J. E. Bennett, and M. A. Huber. 1982. Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis. J. Clin. Investig.69:1185-1190.","journal-title":"J. Clin. Investig."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.4049\/jimmunol.129.4.1675","volume":"129","year":"1982","unstructured":"Kozel, T. R., and E. C. Gotschlich. 1982. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J. Immunol.129:1675-1680.","journal-title":"J. Immunol."},{"key":"e_1_3_2_13_2","first-page":"295","volume":"5","year":"1958","unstructured":"Louria, D. B. 1958. Some aspects of the absorption, distribution, and excretion of amphotericin B in man. Antibiot. Med. Clin. Ther.5:295-301.","journal-title":"Antibiot. Med. Clin. Ther."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/mmy.39.1.19.30"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.8.1825"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.2.233"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1086\/313757"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"37561","DOI":"10.1074\/jbc.M306137200","volume":"278","year":"2003","unstructured":"Sau, K., S. S. Mambula, E. Latz, P. Henneke, D. T. Golenbock, and S. M. Levitz. 2003. The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J. Biol. Chem.278:37561-37568.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/mmy.41.1.15.19","volume":"41","year":"2003","unstructured":"Shadkchan, Y., Z. Zaslavsky, and E. Segal. 2003. Pharmacokinetics of amphotericin B in serum and tissues in mice treated with amphotericin B-Intralipid. Med. Mycol.41:15-19.","journal-title":"Med. Mycol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.8.1919"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/mmy.38.6.407.417"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.5.796"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.58.5.1296-1300.1990"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb35905.x"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.10.4358-4361.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.10.4358-4361.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T19:55:01Z","timestamp":1683230101000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.49.10.4358-4361.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1128\/AAC.49.10.4358-4361.2005"],"URL":"https:\/\/doi.org\/10.1128\/aac.49.10.4358-4361.2005","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"2005-06-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-07-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-10-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}